Related Experiment Video
Updated: Jul 5, 2026

In Vivo Electrophysiological Measurement of Compound Muscle Action Potential from the Forelimbs in Mouse Models of Motor Neuron Degeneration
Published on: June 15, 2018
Severe early-onset axonal neuropathy with homozygous and compound heterozygous MFN2 mutations
G A Nicholson1, C Magdelaine, D Zhu
1Molecular Medicine Laboratory and ANZAC Research Institute, Clinical Sciences Building, Concord Hospital, NSW 2139, Australia. garthn@med.usyd.edu.au
Objective:
Severe early-onset axonal neuropathy (SEOAN) is a heterogeneous phenotype first delineated by Ouvrier et al., characterized by progressive axonal degeneration with gait problems often progressing to wheelchair requirement and later respiratory involvement. Most cases are sporadic single cases. Some have heterozygous mitofusin 2 (MFN2) mutations, many of which are de novo dominant mutations. The aim of this study was to investigate the mode of inheritance in three individuals with severe early-onset axonal neuropathy and homozygous or compound heterozygous MFN2 mutations.
Methods:
The clinical and molecular findings in the parents of three individuals with SEOAN with homozygous or compound heterozygous MFN2 mutations were examined.
Results:
All parents were asymptomatic or mildly symptomatic with some signs of peripheral neuropathy indicating a minimal phenotype. Two had hearing problems. All parents carried the relevant single base (heterozygous) MFN2 variations.
Conclusion:
Severe early-onset axonal neuropathy due to MFN2 mutations can present as an apparently recessively inherited neuropathy but the minimal phenotype in the parents suggests a semi-dominant mechanism.
Related Concept Videos
Multiple Sclerosis l: Introduction
Huntington Disease l: Introduction

